Table 1 ABCB1 SNPs demonstrate significant association with clinical outcome in patients enrolled in GO arm of the randomized AAML0531 clinical trial

From: ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial

ABCB1 SNPs

Differences by ABCB1 genotypes within No-GO or GO arm

ABCB1 SNP_rs1045642

No-GO ARM (rs1045642)

GO-ARM (rs1045642)

 

% ± 2SE%

% ± 2SE%

% ± 2SE%

p

p

% ± 2SE%

% ± 2SE%

% ± 2SE%

p

p

 

CC (N = 132)

CT (N = 244)

TT (N = 93)

CC vs. CT vs. TT

CC vs. CT+TT

CC (N = 128)

CT (N = 238)

TT (N = 102)

CC vs. CT vs. TT

CC vs. CT+TT

5 years OS

63 ± 9%

62 ± 6%

70 ± 10%

0.323

0.371

59 ± 9%

66 ± 7%

71 ± 10%

0.123

0.068

5 years EFS

50 ± 9%

44 ± 6%

48 ± 11%

0.633

0.466

44 ± 9%

55 ± 7%

56 ± 10%

0.073

0.022

 

CC (N = 91)

CT (N = 171)

TT (N = 64)

CC vs. CT vs. TT

CC vs. CT+TT

CC (N = 97)

CT (N = 182)

TT (N = 77)

CC vs. CT vs. TT

CC vs. CT+TT

5 years DFS from EOC1

56 ± 11%

50 ± 8%

55 ± 13%

0.441

0.472

51 ± 10%

62 ± 7%

64 ± 11%

0.126

0.044

5 years RR from EOC1

40 ± 11%

47 ± 8%

43 ± 13%

0.378

0.278

45 ± 10%

30 ± 7%

28 ± 10%

0.024

0.007

ABCB1 SNP_rs2235015

No-GO ARM (rs2235015)

GO ARM (rs2235015)

% ± 2SE%

% ± 2SE%

% ± 2SE%

p

p

% ± 2SE%

% ± 2SE%

% ± 2SE%

p

p

 

GG (N = 300)

GT (N = 141)

TT (N = 24)

GG vs. GT vs. TT

GG+GT vs. TT

GG (N = 295)

GT (N = 141)

TT (N = 27)

GG vs. GT vs. TT

GG+GT vs. TT

5 years OS

64 ± 6%

63 ± 8%

66 ± 20%

0.848

0.954

65 ± 6%

68 ± 8%

54 ± 20%

0.450

0.247

5 years EFS

46 ± 6%

49 ± 9%

41 ± 20%

0.892

0.644

52 ± 6%

55 ± 8%

37 ± 19%

0.303

0.156

 

GG (N = 212)

GT (N = 94)

TT (N = 16)

GG vs. GT vs. TT

GG+GT vs. TT

GG (N = 219)

GT (N = 111)

TT (N = 22)

GG vs. GT vs. TT

GG+GT vs. TT

5 years DFS from EOC1

52 ± 7%

55 ± 10%

49 ± 26%

0.934

0.719

60 ± 7%

60 ± 9%

41 ± 21%

0.286

0.118

5 years RR from EOC1

46 ± 7%

40 ± 10%

45 ± 27%

0.851

0.929

33 ± 7%

30 ± 9%

59 ± 22%

0.046

0.016

  1. The bold values indicate statistically significant p value of <0.05